GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Curocell Inc (XKRX:372320) » Definitions » Other Current Payables

Curocell (XKRX:372320) Other Current Payables : ₩1,380.47 Mil (As of Jun. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Curocell Other Current Payables?

Curocell's Other Current Payables for the quarter that ended in Jun. 2023 was ₩1,380.47 Mil.

Curocell's quarterly Other Current Payables increased from Jun. 2022 (₩0.00 Mil) to Dec. 2022 (₩4,398.89 Mil) but then declined from Dec. 2022 (₩4,398.89 Mil) to Jun. 2023 (₩1,380.47 Mil).

Curocell's annual Other Current Payables increased from Dec. 2021 (₩875.54 Mil) to Dec. 2022 (₩4,398.89 Mil) but then declined from Dec. 2022 (₩4,398.89 Mil) to Dec. 2023 (₩1,634.23 Mil).


Curocell Other Current Payables Historical Data

The historical data trend for Curocell's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curocell Other Current Payables Chart

Curocell Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Payables
239.97 396.51 875.54 4,398.89 1,634.23

Curocell Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Other Current Payables - 4,398.89 1,380.47 1,634.23

Curocell Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.


Curocell Other Current Payables Related Terms

Thank you for viewing the detailed overview of Curocell's Other Current Payables provided by GuruFocus.com. Please click on the following links to see related term pages.


Curocell (XKRX:372320) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
11, Gukjegwahak 16-ro, Yuseong-gu, Daejeon, KOR, 34002
Curocell Inc is engaged in medical and pharmaceutical research and development. The company is into development of CAR-T treatments that enhance the natural function of immune cells to eliminate cancer cells through genetic manipulation of human immune cells.

Curocell (XKRX:372320) Headlines

No Headlines